Diagnosis and Management of Upper Tract Urothelial Carcinoma.

While UTUC is relatively uncommon, it has an aggressive natural history and poor prognosis, which has not substantially improved over the past two decades. Nevertheless, continued research has led to the discovery of risk factors improving the prevention and early detection of UTUC. Although RNU remains the standard treatment for localized invasive UTUC, nephron-sparing surgery for selected patients has made considerable progress in the recent years. The stagnation in the prognosis of UTUC over the past two decades highlights the necessity for incorporating multimodal approaches including refinements in systemic chemotherapy and radiotherapy to attain better outcomes for patients with UTUC.

Diluição celular, características do meio de cultura e biorreatores de imersão temporária na diferenciação e regeneração de células em suspensão de bananeira

Altos custos de produção geralmente limitam o uso comercial da micropropagação. O uso de meios de cultura líquidos é considerado uma solução para a automação e redução de custos. Entretanto, dependendo da cultivar de bananeira, esse processo pode mostrar diferentes níveis de dificuldade, e adaptações nos protocolos são necessárias. Neste estudo, experimentos de diferenciação celular e regeneração de plantas foram desenvolvidos em células em suspensão de banana pela avaliação da densidade inicial de células, meios de cultura e sistemas de imersão temporária. Para tanto, uma sequência de três experimentos foi realizada: o primeiro avaliou os efeitos da densidade celular (0,5; 1 e 2 mL), meios de cultura (M1: 1/2MS, 0,1 g.L-1 de ácido ascórbico, 0,1 g.L-1 de L-prolina, 30 g.L-1 de sacarose e 10 µM de 2iP; M2: MS, 30 g.L-1 de sacarose, 2,2 µM de BAP e 11,4 µM de AIA) e períodos de diferenciação celular (40 e 130 dias); o segundo experimento analisou o efeito do tamanho dos propágulos diferenciados em meio líquido (aprox. 2,5; 5 e 10 mm em diâmetro) na formação de embriões somáticos ou na regeneração de plantas; finalmente, um terceiro experimento avaliou o efeito de sistemas de cultivo com papel-filtro cobrindo o meio de cultura semissólido e sistemas de imersão temporários na diferenciação dos propágulos e na regeneração de plantas. Não foram observadas diferenças significativas entre os meios de diferenciação, porém as melhores diluições de células para a diferenciação foram de 1 e 2 mL/30mL de meio de cultura, enquanto diluições de 0,5 mL/30 mL de meio aumentaram a oxidação celular. A extensão do período de diferenciação de 40 para 130 dias foi importante para produzir maior número de calos/propágulos uniformes e com pelo menos de 10 mm de diâmetro, que puderam ser usados em sistemas de imersão temporária (biorreatores) para a diferenciação de embriões somáticos e regeneração de plantas. Considerando todos os sistemas de regeneração, verificou-se que o uso de meios de regeneração de consistência semissólida com papel-filtro na superfície do meio é o mais responsivo para a diferenciação de embriões somáticos e regeneração de plantas.

Clear Cell Papillary Renal Cell Carcinoma and Renal Angiomyoadenomatous Tumor: Two Variants of a Morphologic, Immunohistochemical, and Genetic Distinct Entity of Renal Cell Carcinoma.

Clear cell papillary renal cell carcinoma (ccpRCC) and renal angiomyoadenomatous tumor (RAT) share morphologic similarities with clear cell (ccRCC) and papillary RCC (pRCC). It is a matter of controversy whether their morphologic, immunophenotypic, and molecular features allow the definition of a separate renal carcinoma entity. The aim of our project was to investigate specific renal immunohistochemical biomarkers involved in the hypoxia-inducible factor pathway and mutations in the VHL gene to clarify the relationship between ccpRCC and RAT. We investigated 28 ccpRCC and 9 RAT samples by immunohistochemistry using 25 markers. VHL gene mutations and allele losses were investigated by Sanger sequencing and fluorescence in situ hybridization. Clinical follow-up data were obtained for a subset of the patients. No tumor recurrence or tumor-related death was observed in any of the patients. Immunohistochemistry and molecular analyses led to the reclassification of 3 tumors as ccRCC and TFE3 translocation carcinomas. The immunohistochemical profile of ccpRCC and RAT samples was very similar but not identical, differing from both ccRCC and pRCC. Especially, the parafibromin and hKIM-1 expression exhibited differences in ccpRCC/RAT compared with ccRCC and pRCC. Genetic analysis revealed VHL mutations in 2/27 (7%) and 1/7 (14%) ccpRCC and RAT samples, respectively. Fluorescence in situ hybridization analysis disclosed a 3p loss in 2/20 (10%) ccpRCC samples. ccpRCC and RAT have a specific morphologic and immunohistochemical profile, but they share similarities with the more aggressive renal tumors. On the basis of our results, we regard ccpRCC/RAT as a distinct entity of RCCs.

Lymphoepithelial carcinoma in the maxillary sinus: a case report.

INTRODUCTION: Lymphoepithelial carcinoma of the maxillary sinus is a very rare malignancy and it can be difficult to make a pre-operative diagnosis. CASE PRESENTATION: A 72-year-old Caucasian woman presented to our facility with an isolated right-side epistaxis that had been present for three months, with the results of a computed tomography scan showing a soft tissue mass in the right maxillary sinus with an impacted tooth. The results of a transnasal endoscopic biopsy were compatible with a lymphoepithelial carcinoma, following which our patient underwent a radical excision of the mass. The final histology results revealed lymphoepithelial carcinoma of the maxillary sinus with negative assays for Epstein-Barr virus. Our patient was given post-operative external radiotherapy and has remained disease-free at three-year follow-up. CONCLUSIONS: This report details the diagnosis and management of a case of lymphoepithelial carcinoma of the maxillary sinus, which is a very rare malignant tumor with very little mention in the literature. Only a strong suspicion with systematic use of various patho-immunological tests helps to arrive at a definitive diagnosis by excluding other better-known tumors.